Amneal Pharmaceuticals, Inc. (AMRX)
17.53
-0.48
(-2.67%)
USD |
NASDAQ |
Aug 28, 15:37
Amneal Pharmaceuticals Cash from Operations (Quarterly) : -21.24M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.24M |
| March 31, 2026 | -28.72M |
| December 31, 2025 | 130.32M |
| September 30, 2025 | 118.45M |
| June 30, 2025 | 83.82M |
| March 31, 2025 | 7.408M |
| December 31, 2024 | 118.01M |
| September 30, 2024 | 141.77M |
| June 30, 2024 | 39.66M |
| March 31, 2024 | -4.41M |
| December 31, 2023 | -26.05M |
| September 30, 2023 | 80.84M |
| June 30, 2023 | -11.34M |
| March 31, 2023 | 139.71M |
| December 31, 2022 | -23.29M |
| September 30, 2022 | 93.57M |
| June 30, 2022 | -81.52M |
| March 31, 2022 | 76.34M |
| December 31, 2021 | 63.26M |
| September 30, 2021 | 82.36M |
| June 30, 2021 | -51.93M |
| March 31, 2021 | 148.13M |
| December 31, 2020 | 105.96M |
| September 30, 2020 | 44.78M |
| June 30, 2020 | 179.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.03M |
| December 31, 2019 | -50.89M |
| September 30, 2019 | 139.91M |
| June 30, 2019 | 21.09M |
| March 31, 2019 | -108.41M |
| December 31, 2018 | 259.65M |
| September 30, 2018 | 62.13M |
| June 30, 2018 | -98.58M |
| March 31, 2018 | 27.03M |
| December 31, 2017 | 70.29M |
| September 30, 2017 | 68.49M |
| June 30, 2017 | 56.42M |
| March 31, 2017 | 38.99M |
| December 31, 2016 | -23.17M |
| September 30, 2016 | 73.98M |
| June 30, 2016 | -53.67M |
| March 31, 2016 | 77.46M |
| December 31, 2015 | 36.85M |
| September 30, 2015 | 67.66M |
| June 30, 2015 | -56.24M |
| March 31, 2015 | 23.66M |
| December 31, 2014 | -21.12M |
| September 30, 2014 | 41.52M |
| June 30, 2014 | 29.50M |
| March 31, 2014 | -17.08M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Liquidia Corp. | 80.24M |
| Eli Lilly & Co. | 10.69B |
| Indivior Pharmaceuticals, Inc. | 228.52M |
| Viatris, Inc. | 381.80M |
| Pfizer Inc. | 835.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -123.14M |
| Cash from Financing (Quarterly) | 79.76M |
| Free Cash Flow | -14.29M |
| Free Cash Flow Per Share (Quarterly) | -0.4388 |
| Free Cash Flow to Equity (Quarterly) | -239.26M |
| Free Cash Flow to Firm (Quarterly) | -90.01M |
| Free Cash Flow Yield | -0.25% |